ARGOS THERAPEUTICS INC's ticker is ARGSXXXX and the CUSIP is 040221103. A total of 44 filers reported holding ARGOS THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 0.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $157,000 | +3.3% | 1,045,386 | +22.8% | 0.00% | – |
| Q3 2017 | $152,000 | -46.5% | 851,235 | +9.1% | 0.00% | – |
| Q2 2017 | $284,000 | -25.7% | 780,035 | -7.9% | 0.00% | – |
| Q1 2017 | $382,000 | -90.0% | 847,123 | +8.3% | 0.00% | – |
| Q4 2016 | $3,834,000 | +4.9% | 782,336 | +6.4% | 0.00% | – |
| Q3 2016 | $3,655,000 | +58.0% | 735,381 | +94.8% | 0.00% | – |
| Q2 2016 | $2,314,000 | +50.6% | 377,497 | +57.2% | 0.00% | – |
| Q1 2016 | $1,537,000 | +304.5% | 240,107 | +45.9% | 0.00% | – |
| Q4 2015 | $380,000 | -99.8% | 164,565 | -96.7% | 0.00% | -100.0% |
| Q3 2015 | $180,983,000 | +17574.1% | 4,921,822 | +3192.5% | 0.01% | – |
| Q2 2015 | $1,024,000 | -19.7% | 149,485 | +4.4% | 0.00% | – |
| Q1 2015 | $1,276,000 | +1.4% | 143,205 | +13.8% | 0.00% | – |
| Q4 2014 | $1,258,000 | +0.2% | 125,843 | +0.8% | 0.00% | – |
| Q3 2014 | $1,256,000 | +48.3% | 124,843 | +18.4% | 0.00% | – |
| Q2 2014 | $847,000 | -24.6% | 105,431 | -6.2% | 0.00% | – |
| Q1 2014 | $1,124,000 | – | 112,399 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pharmstandard International S.A. | 13,242,279 | $5,984,000 | 15.97% |
| Pharmstandard International S.A. | 5,120,604 | $2,314,000 | 6.17% |
| SANDERS MORRIS HARRIS LLC | 290,424 | $132,000 | 0.02% |
| WEDBUSH SECURITIES INC | 63,500 | $29,000 | 0.00% |
| Virtu KCG Holdings LLC | 127,073 | $57,000 | 0.00% |
| Alyeska Investment Group, L.P. | 200,000 | $90,000 | 0.00% |
| WASATCH ADVISORS LP | 186,900 | $85,000 | 0.00% |
| STATE STREET CORP | 184,194 | $82,000 | 0.00% |
| SG Americas Securities, LLC | 17,652 | $8,000 | 0.00% |
| MEEDER ASSET MANAGEMENT INC | 398 | $0 | 0.00% |